| Views | |
|---|---|
| A Phase I/II first-line study of R-CHOP plus B-cell receptor/NF-κB-double-targeting to molecularly assess therapy response | 408 |
| October 2025 | November 2025 | December 2025 | January 2026 | February 2026 | March 2026 | April 2026 | |
|---|---|---|---|---|---|---|---|
| A Phase I/II first-line study of R-CHOP plus B-cell receptor/NF-κB-double-targeting to molecularly assess therapy response | 28 | 17 | 9 | 9 | 9 | 17 | 8 |
| Views | |
|---|---|
| 2019_Denker_etal.pdf | 191 |
